Showing results (231-240 of 261) with videos related to
Sort By:
Pageof 27
Lancet (London, England)|August 12, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trialsKenneth B Gordon, Bruce Strober, Mark Lebwohl, et al.Frontiers in Neurology|September 30, 2021
Study Protocol for the Development of a European eHealth Platform to Improve Quality of Life in Individuals With Huntington's Disease and Their Partners (HD-eHelp Study): A User-Centered Design ApproachPearl J C van Lonkhuizen, Niko J H Vegt, Eline Meijer, et al.Dermatology and Therapy|June 17, 2026
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment AdherenceJonathan I Silverberg, Alan D Irvine, Peter Foley, et al.Dermatology and Therapy|March 23, 2020
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled TrialsCraig Leonardi, Kristian Reich, Peter Foley, et al.Journal of the American Academy of Dermatology|April 5, 2023
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areataCheng Zhou, Xiumin Yang, Bin Yang, et al.Frontiers in Oncology|July 15, 2026
SinglePass electrocautery device for closure of lung and mediastinal biopsy: a case series of 5 patientsTust Techasith, Abhishek Jairam, Benjamin Park, et al.International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.Journal of Cutaneous Medicine and Surgery|April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDTPiergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.Molecular Therapy Oncolytics|May 6, 2020
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell ToxicityJoanne A Hammill, Jacek M Kwiecien, Anna Dvorkin-Gheva, et al.BMJ Open|January 18, 2023
Examining the benefit of graduated compression stockings in the prevention of hospital-associated venous thromboembolism in low-risk surgical patients: a multicentre cluster randomised controlled trial (PETS trial)Matthew Machin, Sarrah Peerbux, Sarah Whittley, et al.Pageof 27